advertisement

---

Journal of Ocular Pharmacology and Therapeutics 12

Showing records 1 to 12 | Display all abstracts in Journal of Ocular Pharmacology and Therapeutics

98833 Phase 2b, Randomized, 3-Month, Dose-Finding Study of Sepetaprost in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: The ANGEL Study
Wirta DL
Journal of Ocular Pharmacology and Therapeutics 2022; 38: 240-251

---

98583 Transport of Vitamin E from Ethanol/Water Solution into Contact Lenses and Impact on Drug Transport
Liu Z
Journal of Ocular Pharmacology and Therapeutics 2022; 38: 396-403

---

98993 Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: Results from the VISIONARY Study Population in Spain
Garcia-Medina JJ
Journal of Ocular Pharmacology and Therapeutics 2022; 38: 252-260

---

98833 Phase 2b, Randomized, 3-Month, Dose-Finding Study of Sepetaprost in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: The ANGEL Study
Kuwayama Y
Journal of Ocular Pharmacology and Therapeutics 2022; 38: 240-251

---

98993 Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: Results from the VISIONARY Study Population in Spain
Benitez-del-Castillo J
Journal of Ocular Pharmacology and Therapeutics 2022; 38: 252-260

---

98583 Transport of Vitamin E from Ethanol/Water Solution into Contact Lenses and Impact on Drug Transport
Overton M; Chauhan A
Journal of Ocular Pharmacology and Therapeutics 2022; 38: 396-403

---

98833 Phase 2b, Randomized, 3-Month, Dose-Finding Study of Sepetaprost in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: The ANGEL Study
Lu F
Journal of Ocular Pharmacology and Therapeutics 2022; 38: 240-251

---

98993 Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: Results from the VISIONARY Study Population in Spain
Rodríguez-Agirretxe I
Journal of Ocular Pharmacology and Therapeutics 2022; 38: 252-260

---

98833 Phase 2b, Randomized, 3-Month, Dose-Finding Study of Sepetaprost in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: The ANGEL Study
Shao H
Journal of Ocular Pharmacology and Therapeutics 2022; 38: 240-251

---

98993 Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: Results from the VISIONARY Study Population in Spain
Lopez-Lopez F; Moreno-Valladares A
Journal of Ocular Pharmacology and Therapeutics 2022; 38: 252-260

---

98833 Phase 2b, Randomized, 3-Month, Dose-Finding Study of Sepetaprost in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: The ANGEL Study
Odani-Kawabata N
Journal of Ocular Pharmacology and Therapeutics 2022; 38: 240-251

---

98993 Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: Results from the VISIONARY Study Population in Spain

Journal of Ocular Pharmacology and Therapeutics 2022; 38: 252-260

---